Cardiorenal Metabolic Syndrome and Cardiometabolic Risks in Minority Populations

Cardiorenal Medicine

Farhad Zangeneh¹  Priscilla E. Pemu¹  Elizabeth O. Ofili¹  JoAnne Micale Foody¹  Samar A. Nasser¹  Gary A. Puckrein¹  Michael Mansour¹  A. Enrique Caballero¹  Keith C. Ferdinand¹  Fatima Rodriguez¹ 

[1] $$

关键词: Cardiorenal metabolic syndrome;    Cardiometabolic risk;    Metabolic syndrome;    Racial/ethnic minorities;    Disparities;   

DOI  :  10.1159/000357236

来源: S Karger AG

【 摘 要 】

Cardiovascular disease (CVD), including heart disease and stroke, is the leading cause of death in the USA, regardless of self-determined race/ethnicity, and largely driven by cardiometabolic risk (CMR) and cardiorenal metabolic syndrome (CRS). The primary drivers of increased CMR include obesity, hypertension, insulin resistance, hyperglycemia, dyslipidemia, chronic kidney disease as well as associated adverse behaviors of physical inactivity, smoking, and unhealthy eating habits. Given the importance of CRS for public health, multiple stakeholders, including the National Minority Quality Forum (the Forum), the American Association of Clinical Endocrinologists (AACE), the American College of Cardiology (ACC), and the Association of Black Cardiologists (ABC), have developed this review to inform clinicians and other health professionals of the unique aspects of CMR in racial/ethnic minorities and of potential means to improve CMR factor control, to reduce CRS and CVD in diverse populations, and to provide more effective, coordinated care. This paper highlights CRS and CMR as sources of significant morbidity and mortality (particularly in racial/ethnic minorities), associated health-care costs, and an evolving index tool for cardiometabolic disease to determine geographical and environmental factors. Finally, this work provides a few examples of interventions potentially successful at reducing disparities in cardiometabolic health.

【 授权许可】

Unknown